RET Inhibitor: Clinical Trials

2 trials of RET Inhibitor, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 recruiting. .

Follow RET Inhibitor: new trials by email Literature Review of RET Inhibitor trials Research Report on RET Inhibitor

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Response to Neoadjuvant Treatment in Locally Advanced Thyroid Cancer
Multitarget Tyrosine Kinase Inhibitors, BRAF inhibitor dabrafenib and MEK inhibitor trametinib, RET Inhibitor - Thyroid Cancer, Thyroid Neoplasms
RecruitingFujian Medical University1202025-12-232026-02-19
RET Inhibitor for Neoadjuvant Therapy in Locally Advanced RET-altered Thyroid Cancer
RET Inhibitor, Surgery - Thyroid Cancer
RecruitingFudan University482024-07-182024-08-02

Conditions studied

Thyroid Neoplasms (2)

Sponsors

Fudan University (1)  ·  Fujian Medical University (1)

Countries

China (2)